Comprehensive Psychiatry
Volume 46, Issue 6 , Pages 453-459 , November 2005

Quality of life in obsessive-compulsive disorder before and after treatment

  • Steffen Moritz

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 40 42803 6565; fax: +49 40 42803 5121.
    • ,
  • Michael Rufer

      Affiliations

    • Department of Psychiatry, University Hospital of Zürich, 8091 Zürich, Switzerland
    • ,
  • Susanne Fricke

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany
    • ,
  • Anne Karow

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany
    • ,
  • Matthias Morfeld

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany
    • ,
  • Lena Jelinek

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany
    • ,
  • Dirk Jacobsen

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, D-20246 Hamburg, Germany

References 

  1. Bullinger M, Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand. Göttingen (Germany): Hogrefe; 1998;
  2. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669–682
  3. Moritz S, Woodward TS, Krausz M, Naber D. Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication. Int Clin Psychopharmacol. 2002;17:41–44
  4. Koran LM, Thienemann ML, Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am J Psychiatry. 1996;153:783–788
  5. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ. Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder and panic disorder. Psychopathology. 2003;36:255–262
  6. Bobes J, Gonzalez MP, Bascaran MT, Arango C, Saiz PA, Bousono M. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry. 2001;16:239–245
  7. Monti M, Sambvani N, Sacrini F. Obsessive-compulsive disorders in dermatology. J Eur Acad Dermatol Venereol. 1998;11:103–108
  8. Malik ML, Connor KM, Sutherland SM, Smith RD, Davison RM, Davidson JR. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. J Trauma Stress. 1999;12:387–393
  9. Bystritsky A, Liberman RP, Hwang S, et al. Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders. Depress Anxiety. 2001;14:214–218
  10. Hollander E, Kwon JH, Stein DJ, Broatch J, Rowland CT, Himelein CA. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry. 1996;(57, Suppl 8):3–6
  11. Sorensen CB, Kirkeby L, Thomsen PH. Quality of life with OCD. A self-reported survey among members of the Danish OCD association. Nord J Psychiatry. 2004;58:231–236
  12. Koran LM. Quality of life in obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:509–517
  13. Moritz S, Meier B, Hand I, Schick M, Jahn H. Dimensional structure of the Hamilton depression rating scale in patients with obsessive-compulsive disorder. Psychiatry Res. 2004;125:171–180
  14. Fricke S, Moritz S, Andresen B, et al. Einfluss von Persönlichkeitsstörungen auf den Erfolg eines multimodalen Verhaltenstherapie—Teil II: Ergebnisse einer empirischen Studie (Impact of personality disorders on treatment outcome in obsessive-compulsive disorder — part II: results of an empirical study), Verhaltenstherapie. 2003;13:172–183
  15. Fricke S, Moritz S, Andresen B, et al. Do personality disorders predict negative treatment outcome in obsessive-compulsive disorders? A prospective 6-month follow-up study. Treatment outcome in OCD and personality disorders. Eur Psychiatry [in press].
  16. Ware JE, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Lincoln (RI): QualityMetric Incorporated; 1993;
  17. Moritz S, Fricke S, Jacobsen D, et al. Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder. Behav Res Ther. 2004;42:217–227
  18. Hafner RJ, Gilchrist P, Bowling J, Kalucy R. The treatment of obsessional neurosis in a family setting. Aust N Z J Psychiatry. 1981;15:145–151
  19. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1997;65:44–52
  20. Abramowitz JS. Does cognitive-behavioral therapy cure obsessive-compulsive disorder? A meta-analytic evaluation of clinical significance. Behav Ther. 1998;29:339–355
  21. Besiroglu L, Cilli AS, Askin R. The predictors of health care seeking behavior in obsessive-compulsive disorder. Compr Psychiatry. 2004;45:99–108
  22. Pallanti S, Hollander E, Bienstock C, et al. Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5:181–191
  23. Bystritsky A, Saxena S, Maidment K, Vapnik T, Tarlow G, Rosen R. Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program. Psychiatr Serv. 1999;50:412–414
  24. Tenney NH, Denys DA, van Megen HJ, Glas G, Westenberg HG. Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol. 2003;18:29–33
  25. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The MINI International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry. 1998;59(Suppl 20):22–33
  26. Hand I. Out-patient, multimodal behaviour therapy for obsessive-compulsive disorder. Br J Psychiatry. 1998;173(Suppl 35):45–52
  27. Hand I, Büttner-Westphal H. Die Yale-Brown Obsessive Compulsive Scale (Y-BOCS): ein halbstrukturiertes Interview zur Beurteilung des Schweregrades von Denk- und Handlungszwängen. Verhaltenstherapie. 1991;1:223–225
  28. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011
  29. Klepsch R, Zaworka W, Hand I, Lünenschloss K, Jauernig G. Derivation and validation of the Hamburg Obsession/Compulsion Inventory—Short Form (HOCI-S): first results. Psychol Assess. 1991;3:196–201
  30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  31. Beck AT, Steer RA. Beck Depression Inventory—manual. San Antonio: The Psychological Corporation; 1987;
  32. Moritz S, Kloss M, Jacobsen D, Wein C, Fricke S, Hand I. Dimensional structure of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Psychiatry Res. 2002;109:193–199
  33. Rufer M, Hand I, Alsleben H, et al. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo. A 7-year follow-up of a randomized double-blind trial. Eur Arch Psychiatry Clin Neurosci. 2005;255:121–128
  34. Rufer M, Held D, Cremer J, et al. Dissociation as a predictor of cognitive-behavior therapy outcome in patients with obsessive compulsive disorder. Psychother Psychosom [in press].
  35. World Health Organization. World Health Organization constitution. Geneva: World Health Organization; 1948;
  36. Demal U, Lenz G, Mayrhofer A, Zapotoczky HG, Zitterl W. Obsessive-compulsive disorder and depression. A retrospective study on course and interaction. Psychopathology. 1993;26:145–150

PII: S0010-440X(05)00050-7

doi: 10.1016/j.comppsych.2005.04.002

Comprehensive Psychiatry
Volume 46, Issue 6 , Pages 453-459 , November 2005

Article Tools

* Image Usage & Resolution